Skip to main content

Table 2 General traits and physical activity levels of overweight/obese patients with non-alcoholic fatty liver disease (NAFLD)

From: Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial

Variables Nanocurcumin (n = 42) n(%) or Mean(SD) Placebo (n = 42) n(%) or Mean(SD) P-value
Age (yrs) 41.8(5.6) 42.5(6.2) 0.2*
Gender male 23(54.8) 23(54.8) 1.0**
female 19(45.2) 19(45.2)
Height (cm) 167.8(9.8) 167.7(9.0) 0.8*
Marriage status single 5(11.9) 7(16.7) 0.5**
married 37(88.1) 35(83.3)
Job status employee, free job/retired 31(73.8) 25(59.5) 0.1**
housewife, unemployed 11(26.2) 17(40.5)
Education level up to associate degree 21(50) 20(47.6) 0.8**
Bachelor and higher 21(50) 22(52.4)
Economic level Low (≤3 living items) 0(0) 0(0) 0.8**
moderate (4–6 living items) 19(45.2) 18(42.9)
High (≥7 living items) 23(54.8) 24(57.1)
Physical activity level (Baseline) low (< 600 MET-minutes/week) 31(73.8) 28(66.7) 0.4**
Moderate (600 to < 1500 MET-minutes/week) 11(26.2) 14(33.3)
High (≥ 1500 MET-minutes/week) 0(0) 0(0)
Physical activity level (After 3 months) low (< 600 MET-minutes/week) 27(64.3) 26(61.9) 0.8$
Moderate (600 to < 1500 MET-minutes/week) 15(35.7) 16(38.1)
High (≥ 1500 MET-minutes/week) 0(0) 0(0)
Fatty liver (Baseline) No 0(0) 0(0) 0.5**
Yes Mild 35(83.3) 37(88.1)
Moderate 7(16.7) 5(11.9)
Severe 0(0) 0(0)
Fatty liver (After 3 months) No 20(47.6) 5(11.9) < 0.001**
Yes Mild 21(50.0) 33(78.6)
Moderate 1(2.4) 4(9.5)
Severe 0(0) 0(0)
  1. *Mann-Whitney; **Chi-square; $Fisher exact test